People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Pharma, Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pyxis Oncology, Inc. | — | Pharma | Series D+ | $194.5M | $5.0B | 2019 |
| Verastem, Inc. | — | Pharmaceuticals | Series C | $163.2M | $3.5B | 2011 |
| Werewolf Therapeutics, Inc. | — | Pharmaceuticals | Series C | $128.2M | $2.1B | 2019 |
| TScan Therapeutics, Inc. | — | Biotechnology | Series C | $123.3M | $3.3B | 2019 |
| Newleos Therapeutics, Inc. | — | Biotechnology | Series C | $93.4M | $659.9M | 2025 |
| Salarius Pharmaceuticals, Inc. | — | Biotechnology | Series B | $34.6M | $57.8M | 2014 |
| Immunitas Therapeutics, Inc. | — | Biotechnology | Series B | $29.1M | $717.5M | 2021 |
| ImmuneID, Inc. | — | Biotechnology | Series B | $17.1M | $549.0M | 2020 |
Christoph Westphal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christoph Westphal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Crane | 2 | 7 |
| Lucio Iannone | 2 | 6 |
| Timothy Barberich | 2 | 6 |
| Ittai Harel | 2 | 6 |
| Lea Hachigian | 2 | 2 |
| Peter Barton Hutt | 1 | 14 |
| David Steinberg | 1 | 14 |
| Luke Evnin | 1 | 12 |
| Campbell Murray | 1 | 9 |
| Christopher O'Donnell | 1 | 8 |
| Briggs Morrison | 1 | 8 |
| Geeta Vemuri | 1 | 7 |
| Alon Lazarus | 1 | 7 |
| Derek DiRocco | 1 | 7 |
| Steve Kraus | 1 | 6 |
| David Cordo | 1 | 6 |
| JEFFREY GOLDBERG | 1 | 6 |
| Sakae Asanuma | 1 | 6 |
| Andrew Hedin | 1 | 5 |
| John K. Clarke | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.